Merck & Co. Inc. buy Royal Bank of Canada
Start price
30.03.26
/
50%
€102.80
Target price
30.03.27
€123.30
Performance (%)
2.61%
Price
16:42
€105.48
Summary
This prediction is currently active. With a performance of 2.61%, the BUY prediction by Royal_Bank_of_Canada for Merck & Co. Inc. is trending in the right direction. This prediction currently runs until 30.03.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 0.641% | 0.641% |
| iShares Core DAX® | -0.676% | 4.053% |
| iShares Nasdaq 100 | 0.993% | 10.872% |
| iShares Nikkei 225® | 3.279% | 13.468% |
| iShares S&P 500 | 0.621% | 6.195% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (MRK) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat